Drugs / ALLOB
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT02020590 | Feb 2014 → Sep 2017 | — | Bone Therapeutics S.A | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ALLOB | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02020590 ↗ |
| Modality | Cell therapy | “allogeneic bone-forming cells derived from bone marrow mesenchymal stem cells” PMID 34174963 ↗ Jun 2021 |
| Route | Other | “percutaneous implantation of allogeneic bone-forming cells” PMID 34174963 ↗ Jun 2021 |